Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study

Fig. 2

Mean (mean ± SD) plasma concentration vs. time profiles of oseltamivir and oseltamivir carboxylic underfed conditions (pharmacokinetic concentration sets). a Mean (mean ± SD) plasma concentration time profile of oseltamivir after oral administration of test product (T) and reference product (R) in 40 subjects. b Mean (mean ± SD) plasma concentration time profile of oseltamivir carboxylic after oral administration of test product (T) and reference product (R) in 40 subjects. Notes: T = test product of Oseltamivir Phosphate for Suspension; R = reference product of Oseltamivir Phosphate for Suspension(TAMIFLU®)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us